Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals Inc AMPE

Healthcare
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Recent & Breaking News (OTCPK:AMPE)

AMPE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on Behalf of Ampio Pharmaceuticals, Inc. Shareholders

PR Newswire September 20, 2022

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Newsfile September 19, 2022

TOP RANKED ROSEN LAW FIRM Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

Newsfile September 19, 2022

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Ampio Investors of a Lead Plaintiff Deadline of October 17, 2022

PR Newswire September 19, 2022

Ampio Deadline Alert

Newsfile September 18, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ampio Pharmaceuticals, Inc. - AMPE

Newsfile September 17, 2022

Ampio Deadline Alert

Newsfile September 16, 2022

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

Newsfile September 16, 2022

AMPE SHAREHOLDER ALERT: Jakubowitz Law Reminds Ampio Shareholders of a Lead Plaintiff Deadline of October 17, 2022

PR Newswire September 16, 2022

Ampio Class Action: Levi & Korsinsky Reminds Ampio Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 17, 2022 - AMPE

Newsfile September 15, 2022

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

PR Newswire September 15, 2022

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Newsfile September 15, 2022

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire September 15, 2022

ROSEN, A TOP RANKED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

Newsfile September 14, 2022

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Ampio Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NYSE: AMPE)

PR Newswire September 14, 2022

AMPE Investors Have Opportunity to Lead Ampio Pharmaceuticals, Inc. Securities Fraud Lawsuit

PR Newswire September 13, 2022

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Newsfile September 13, 2022

Ampio Deadline Alert

Newsfile September 12, 2022

AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Newsfile September 12, 2022

Ampio Deadline Alert

Newsfile September 11, 2022